SET Overexpression is Associated with Worse Recurrence-Free Survival in Patients with Primary Breast Cancer Receiving Adjuvant Tamoxifen Treatment

Por Huang, Yu-Hsiang, Chu, Pei-Yi, Chen, Ji-Lin, Huang, Chun-Teng, Lee, Chia-Han, Lau, Ka-Yi, Wang, Wan-Lun, Wang, Yu-Ling, Lien, Pei-Ju, Tseng, Ling-Ming, Liu, Chun-Yu
Publicado no J Clin Med (2018)

Targeting SET to restore PP2A activity disrupts an oncogenic CIP2A-feedforward loop and impairs triple negative breast cancer progression

Por Liu, Chun-Yu, Huang, Tzu-Ting, Chen, Yi-Ting, Chen, Ji-Lin, Chu, Pei-Yi, Huang, Chun-Teng, Wang, Wan-Lun, Lau, Ka-Yi, Dai, Ming-Shen, Shiau, Chung-Wai, Tseng, Ling-Ming
Publicado no EBioMedicine (2019)

Sorafenib analogue SC‐60 induces apoptosis through the SHP‐1/STAT3 pathway and enhances docetaxel cytotoxicity in triple‐negative breast cancer cells

Por Liu, Chun‐Yu, Su, Jung‐Chen, Huang, Tzu‐Ting, Chu, Pei‐Yi, Huang, Chun‐Teng, Wang, Wan‐Lun, Lee, Chia‐Han, Lau, Ka‐Yi, Tsai, Wen‐Chun, Yang, Hsiu‐Ping, Shiau, Chung‐Wai, Tseng, Ling‐Ming, Chen, Kuen‐Feng
Publicado no Mol Oncol (2017)

Varlitinib Downregulates HER/ERK Signaling and Induces Apoptosis in Triple Negative Breast Cancer Cells

Por Liu, Chun-Yu, Chu, Pei-Yi, Huang, Chun-Teng, Chen, Ji-Lin, Yang, Hsiu-Ping, Wang, Wan-Lun, Lau, Ka-Yi, Lee, Chia-Han, Lan, Tien-Yun, Huang, Tzu-Ting, Lin, Po-Han, Dai, Ming-Shen, Tseng, Ling-Ming
Publicado no Cancers (Basel) (2019)

The tyrosine kinase inhibitor nintedanib activates SHP-1 and induces apoptosis in triple-negative breast cancer cells

Por Liu, Chun-Yu, Huang, Tzu-Ting, Chu, Pei-Yi, Huang, Chun-Teng, Lee, Chia-Han, Wang, Wan-Lun, Lau, Ka-Yi, Tsai, Wen-Chun, Chao, Tzu-I, Su, Jung-Chen, Chen, Ming-Huang, Shiau, Chung-Wai, Tseng, Ling-Ming, Chen, Kuen-Feng
Publicado no Exp Mol Med (2017)